iShares Health Innovation Active ETF
NYSE Arca:BMED

  • LAST PRICE
    24.62
  • TODAY'S CHANGE (%)
    0.00 (0.00%)
  • Bid / Lots
    9.85/ 2
  • Ask / Lots
    27.18/ 1
  • Open / Previous Close
    --- / 24.62
  • Day Range
    ---
  • 52 Week Range
    21.72
    26.68
  • Volume
    ---
  • Overall Morningstar Rating
    out of 268 funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.

Holdings Diversification

Asset Class
US Stock		80.3%
Non-US Stock		14.3%
Cash		5.4%
Convertible		0
Non-US Bond		0
Other		0
Sectors
Healthcare94.6%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
United States		84.9%
Europe		4.4%
Canada		1.1%
Asia/Oceania		0.1%
Africa		0
Latin America		0
As of 2024-10-31

Top 10 Holdings

Company NamePositionAllocation
Allocation
1 Month Change
Market Value
BlackRock Cash Funds Treasury SL Agency
Long
6.9%
0.00%
$280.0K
ISRG
Intuitive Surgical Inc
Long
4.8%
+11.59%
$194.0K
BSX
Boston Scientific Corp
Long
4.4%
-9.76%
$179.6K
ARGX
argenx SE ADR
Long
3.3%
-8.76%
$134.3K
GILD
Gilead Sciences Inc
Long
3.0%
+205.88%
$120.1K
Roche Holding AG
Long
2.3%
0.00%
$93.6K
DHR
Danaher Corp
Long
2.3%
+2.18%
$92.1K
ABT
Abbott Laboratories
Long
2.2%
+201.13%
$90.5K
SRPT
Sarepta Therapeutics Inc
Long
2.1%
+20.98%
$87.2K
TECH
Bio-Techne Corp
Long
2.1%
+2.50%
$84.6K
As of 2024-11-15

Reports

  • 11/10/24

    Morningstar ETF Report

    The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.

Morningstar Ratings

Time HorizonStar Rating
Overall Rating
3 Year Rating
5 Year RatingNot Rated
10 Year RatingNot Rated
As of 2024-10-31

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
MSCI ACWI NR USD
Category
Health
Sponsor
BlackRock Fund Advisors
Inception
September 29, 2020
As of 2024-10-31

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Holding Details
Total Net Assets$4.1M
Shares Out.160.0K
Net Asset Value (NAV)$24.65
Prem/Discount to NAV-0.13%
P/E Ratio31.0
Dividend Yield0.03%
Dividend per Share---
Ex-Dividend Date---
Dividend Payment Date---
Beta---
Morningstar Investment StyleHealth
Equity Style
Mid Cap Growth
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.85%
Actual Mgmt. Expense Ratio (MER)0.85%